Market News AIOpen the app

TELO stock news · Telomir Pharmaceuticals

Stories about Telomir Pharmaceuticals (TELO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for TELO

Follow Telomir Pharmaceuticals (TELO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TELO
Free on the App Store and Google Play, or on the web.
  1. Sep 18, 2026, 5:13 PM ET · Market

    On Friday evening, 12 health care stocks saw big changes in their prices.

    Neutral

    Telomir Pharmaceuticals stock declined 8.0% to $1.13 after-market. The article lists only trading moves, so it does not change Telomir's prospects.

  2. Sep 17, 2026, 5:21 PM ET · Market

    On Thursday evening, 12 health care stocks changed a lot in price.

    Neutral

    Telomir Pharmaceuticals shares rose 11.6% to $1.25 after hours, but the article only lists the move and no operational or clinical updates, so it does not change the company's outlook.

  3. Sep 16, 2026, 6:31 PM ET · Market

    Telomir Pharmaceuticals asked its shareholders to vote on important issues.

    Neutral

    Telomir reported annual meeting results; directors and auditor were approved and no operational or financing news was disclosed, so the company's outlook is unchanged.